The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 118:248-249, September 1961
doi: 10.1176/appi.ajp.118.3.248
© 1961 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by COHEN, S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by COHEN, S.

THE PREVENTION AND TREATMENT OF CHEMICAL PARKINSONISM WITH UK-738

SIDNEY COHEN M.D.1

1 Psychosomatic Service, GM&S Hospital, VA Center, Los Angeles 25, Calif.

In the treatment of the long term psychotic patient who will require large amounts of phenothiazines, especially those with a piperazine ring in the side chain, consideration should be given to prevention of the EPS. UK-738 has satisfactorily suppressed these disturbing symptoms without adding undesirable side effects of its own. It has also proven to be an effective agent in the treatment of manifest chemical parkinsonism.







Get information about faster international access.

Privacy Policy

Copyright © 1961 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org